Over 30 years ago, the Kennedy Trust supported the early research and clinical trials that led to the discovery of anti-TNF therapy, a groundbreaking treatment that has improved the lives of millions of patients with musculoskeletal and inflammatory diseases across the globe.

Recognising the importance of conserving this historic impact journey for prosperity, we recently undertook a 2-year project to catalogue the original research papers relating to the discovery. The Kennedy Trust Archive is now publicly available at the Wellcome Collection thanks to the work of our dedicated archivist Annie Lord.

To mark the completion of this archiving project, and to celebrate the 25^th anniversary of the first licencing of infliximab in the US and EU, we are thrilled to announce the launch of our new booklet “Building on a breakthrough: the lasting impact of biologic therapy.”

The booklet chronicles the revolutionary anti-TNF discovery story and highlights the rich history of the Kennedy Trust and our ongoing efforts to further the field of musculoskeletal and inflammatory disease research.

Click here to read the booklet online.